Back to company

Target Biotech ApS: Financial statements 2022

CVR: 39676478

Target Biotech ApS (CVR 39676478) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 402,821 and a net result of DKK 56,725 compared with DKK 87,717 the year before. That is a decrease of 17.3% compared with the year before. Equity amounted to DKK 328,866. The solvency ratio was 92.7%. The company had 1 employee in the financial year.

Gross Profit
402,821 kr.
Profit/Loss
56,725 kr.
Equity
328,866 kr.
Total Assets
354,811 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-403 t.57 t.329 t.1
2021-487 t.88 t.272 t.1
2020-365 t.24 t.184 t.1
2019-221 t.57 t.160 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Target Biotech ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Target Biotech ApS: The 2021 annual report is outApr 19, 2022

Target Biotech ApS has published its annual report for 2021. Gross profit came to DKK 487,080, and the net result was DKK 87,717.

About Target Biotech ApS

Target Biotech ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2018. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Peter Horn Møller. The company is owned by Peter Horn Møller. The company has 0 employees. In 2025, the company reported a gross profit of DKK -19,344 and a net result of DKK -7,028,421 compared with DKK 23,952,623 the year before. Equity amounted to DKK 10,735,912.

Other financial years